\BOOKMARK [0][-]{chapter.1}{1 Introduction: Nanoparticles in medicine and biology}{}% 1
\BOOKMARK [1][-]{section.1.1}{1.1 What are nanoparticles?}{chapter.1}% 2
\BOOKMARK [1][-]{section.1.2}{1.2 Nanoparticles in general are used in nanomedicine \(principally\) and cosmetics}{chapter.1}% 3
\BOOKMARK [1][-]{section.1.3}{1.3 Characterization: Why size \(size distribution, density\) is important?}{chapter.1}% 4
\BOOKMARK [1][-]{section.1.4}{1.4 Dimensional nanometrology and traceability}{chapter.1}% 5
\BOOKMARK [1][-]{section.1.5}{1.5 SAXS is a good tool: small internal electron density differences}{chapter.1}% 6
\BOOKMARK [1][-]{section.1.6}{1.6 advantadges to other characterization tools}{chapter.1}% 7
\BOOKMARK [1][-]{section.1.7}{1.7 contrast variation is even better, but takes too long and extra uncertainties arise}{chapter.1}% 8
\BOOKMARK [1][-]{section.1.8}{1.8 density gradient technique: tunable and large datasets}{chapter.1}% 9
\BOOKMARK [1][-]{section.1.9}{1.9 polymeric particles: why important?}{chapter.1}% 10
\BOOKMARK [1][-]{section.1.10}{1.10 polymeric: extensively used in SAXS and contrast variation, also SANS because deuteration}{chapter.1}% 11
\BOOKMARK [1][-]{section.1.11}{1.11 polymeric: good application because of phase separation in polymerization}{chapter.1}% 12
\BOOKMARK [1][-]{section.1.12}{1.12 bio materials: important why?}{chapter.1}% 13
\BOOKMARK [1][-]{section.1.13}{1.13 liposomal nanocarriers: what are they and why important? How are they characterized?}{chapter.1}% 14
\BOOKMARK [1][-]{section.1.14}{1.14 liposomes: SAXS characterization, literature}{chapter.1}% 15
\BOOKMARK [1][-]{section.1.15}{1.15 liposomes: effects of PEG, cholesterol content, long discussion}{chapter.1}% 16
\BOOKMARK [1][-]{section.1.16}{1.16 liposomal nanocarrier: SAXS characterization, literature, micellesm other bio-drugs}{chapter.1}% 17
\BOOKMARK [1][-]{section.1.17}{1.17 structure of the thesis}{chapter.1}% 18
\BOOKMARK [0][-]{chapter.2}{2 Theoretical Background}{}% 19
\BOOKMARK [1][-]{section.2.1}{2.1 Interaction of X-rays and matter}{chapter.2}% 20
\BOOKMARK [2][-]{subsection.2.1.1}{2.1.1 Beer-Lambert law}{section.2.1}% 21
\BOOKMARK [2][-]{subsection.2.1.2}{2.1.2 Elastic scattering}{section.2.1}% 22
\BOOKMARK [1][-]{section.2.2}{2.2 Small-angle X-ray scattering}{chapter.2}% 23
\BOOKMARK [2][-]{subsection.2.2.1}{2.2.1 Scattering by an ensemble of particles}{section.2.2}% 24
\BOOKMARK [2][-]{subsection.2.2.2}{2.2.2 What is measured in a scattering experiment?: The scattering curve}{section.2.2}% 25
\BOOKMARK [2][-]{subsection.2.2.3}{2.2.3 Modelling of the scattering intensity: Form factors}{section.2.2}% 26
\BOOKMARK [1][-]{section.2.3}{2.3 Contrast variation}{chapter.2}% 27
\BOOKMARK [2][-]{subsection.2.3.1}{2.3.1 Isoscattering point}{section.2.3}% 28
\BOOKMARK [2][-]{subsection.2.3.2}{2.3.2 Basic functions approach}{section.2.3}% 29
\BOOKMARK [0][-]{chapter.3}{3 Instrumentation and experimental setup for SAXS measurements}{}% 30
\BOOKMARK [1][-]{section.3.1}{3.1 Synchrotron radiation}{chapter.3}% 31
\BOOKMARK [2][-]{subsection.3.1.1}{3.1.1 Insertion devices}{section.3.1}% 32
\BOOKMARK [1][-]{section.3.2}{3.2 The BESSY II Electron Storage Ring}{chapter.3}% 33
\BOOKMARK [1][-]{section.3.3}{3.3 FCM Beamline}{chapter.3}% 34
\BOOKMARK [2][-]{subsection.3.3.1}{3.3.1 UHV X-ray Reflectometer}{section.3.3}% 35
\BOOKMARK [1][-]{section.3.4}{3.4 SAXS Setup}{chapter.3}% 36
\BOOKMARK [2][-]{subsection.3.4.1}{3.4.1 X-ray area detector}{section.3.4}% 37
\BOOKMARK [2][-]{subsection.3.4.2}{3.4.2 HZB SAXS instrument and WAXS configuration}{section.3.4}% 38
\BOOKMARK [1][-]{section.3.5}{3.5 Sample environment}{chapter.3}% 39
\BOOKMARK [2][-]{subsection.3.5.1}{3.5.1 Round capillaries}{section.3.5}% 40
\BOOKMARK [2][-]{subsection.3.5.2}{3.5.2 Rectangular capillaries}{section.3.5}% 41
\BOOKMARK [2][-]{subsection.3.5.3}{3.5.3 Cell for low-energies}{section.3.5}% 42
\BOOKMARK [1][-]{section.3.6}{3.6 Data reduction: The scattering curve}{chapter.3}% 43
\BOOKMARK [0][-]{chapter.4}{4 Continuous contrast variation in SAXS: the density gradient technique}{}% 44
\BOOKMARK [1][-]{section.4.1}{4.1 Experimental proceeding}{chapter.4}% 45
\BOOKMARK [2][-]{subsection.4.1.1}{4.1.1 Preparation of the density gradient capillaries}{section.4.1}% 46
\BOOKMARK [2][-]{subsection.4.1.2}{4.1.2 Calibration of the solvent density: X-ray transmission}{section.4.1}% 47
\BOOKMARK [2][-]{subsection.4.1.3}{4.1.3 SAXS measurements}{section.4.1}% 48
\BOOKMARK [1][-]{section.4.2}{4.2 Proof of principle: Application to PS-COOH colloids}{chapter.4}% 49
\BOOKMARK [1][-]{section.4.3}{4.3 Results and data evaluation}{chapter.4}% 50
\BOOKMARK [2][-]{subsection.4.3.1}{4.3.1 Core-shell form factor fit}{section.4.3}% 51
\BOOKMARK [2][-]{subsection.4.3.2}{4.3.2 Isoscattering point}{section.4.3}% 52
\BOOKMARK [2][-]{subsection.4.3.3}{4.3.3 Guinier region}{section.4.3}% 53
\BOOKMARK [2][-]{subsection.4.3.4}{4.3.4 Consistency of the results}{section.4.3}% 54
\BOOKMARK [1][-]{section.4.4}{4.4 Summary and outlook}{chapter.4}% 55
\BOOKMARK [0][-]{chapter.5}{5 Simultaneous size and density determination of polymeric colloids}{}% 56
\BOOKMARK [1][-]{section.5.1}{5.1 Materials and methods}{chapter.5}% 57
\BOOKMARK [2][-]{subsection.5.1.1}{5.1.1 Polymeric particles}{section.5.1}% 58
\BOOKMARK [2][-]{subsection.5.1.2}{5.1.2 Differential Centrifuge Sedimentation \(DCS\)}{section.5.1}% 59
\BOOKMARK [1][-]{section.5.2}{5.2 Determination of the particle size distribution}{chapter.5}% 60
\BOOKMARK [2][-]{subsection.5.2.1}{5.2.1 Inter-laboratory comparison of the mean particle diameter}{section.5.2}% 61
\BOOKMARK [2][-]{subsection.5.2.2}{5.2.2 Particle size distribution of PS-Plain}{section.5.2}% 62
\BOOKMARK [1][-]{section.5.3}{5.3 Considerations about scattering data evaluation}{chapter.5}% 63
\BOOKMARK [2][-]{subsection.5.3.1}{5.3.1 Shape factor formalism}{section.5.3}% 64
\BOOKMARK [2][-]{subsection.5.3.2}{5.3.2 Isoscattering point approach}{section.5.3}% 65
\BOOKMARK [1][-]{section.5.4}{5.4 Determination of the particle physical density}{chapter.5}% 66
\BOOKMARK [2][-]{subsection.5.4.1}{5.4.1 Physical density of PS-Plain: Validation with DCS}{section.5.4}% 67
\BOOKMARK [2][-]{subsection.5.4.2}{5.4.2 Density determination of heavier polymeric colloids}{section.5.4}% 68
\BOOKMARK [1][-]{section.5.5}{5.5 Summary}{chapter.5}% 69
\BOOKMARK [0][-]{chapter.6}{6 Continuous contrast variation applied to relevant bio-materials}{}% 70
\BOOKMARK [1][-]{section.6.1}{6.1 Materials}{chapter.6}% 71
\BOOKMARK [1][-]{section.6.2}{6.2 Traceable size determination of a liposomal drug}{chapter.6}% 72
\BOOKMARK [2][-]{subsection.6.2.1}{6.2.1 Isoscattering point approach}{section.6.2}% 73
\BOOKMARK [2][-]{subsection.6.2.2}{6.2.2 Shape factor calculation}{section.6.2}% 74
\BOOKMARK [2][-]{subsection.6.2.3}{6.2.3 Average electron density}{section.6.2}% 75
\BOOKMARK [1][-]{section.6.3}{6.3 Osmotic effects in liposomes}{chapter.6}% 76
\BOOKMARK [2][-]{subsection.6.3.1}{6.3.1 Application to drug-stabilized liposomes}{section.6.3}% 77
\BOOKMARK [2][-]{subsection.6.3.2}{6.3.2 Does PEGylation affect the osmotic activity of liposomes?}{section.6.3}% 78
\BOOKMARK [1][-]{section.6.4}{6.4 Sizing of blood plasma componenents}{chapter.6}% 79
\BOOKMARK [1][-]{section.6.5}{6.5 Protein-coated low-density nanoparticles}{chapter.6}% 80
\BOOKMARK [2][-]{subsection.6.5.1}{6.5.1 Hard protein corona characterization with contrast variation}{section.6.5}% 81
\BOOKMARK [1][-]{section.6.6}{6.6 Summary}{chapter.6}% 82
\BOOKMARK [0][-]{chapter.7}{7 Summary and outlook}{}% 83
\BOOKMARK [1][-]{section.7.1}{7.1 chap4}{chapter.7}% 84
\BOOKMARK [1][-]{section.7.2}{7.2 chap5}{chapter.7}% 85
\BOOKMARK [1][-]{section.7.3}{7.3 chap6}{chapter.7}% 86
